Autologous Transplantation for Older Adults with AML

While the majority of patients with acute myeloid leukemia (AML) are above the age of 65 years at diagnosis, the outcome of older AML patients remains disappointing. Even if standard intensive chemotherapy induces morphologic complete remission (CR1), relapses in older AML patients are common leadin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mueller, Beatrice U., Seipel, Katja, Bacher, Ulrike, Pabst, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162649/
https://www.ncbi.nlm.nih.gov/pubmed/30235847
http://dx.doi.org/10.3390/cancers10090340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162649/
https://www.ncbi.nlm.nih.gov/pubmed/30235847
http://dx.doi.org/10.3390/cancers10090340

Ejemplares similares